DossierENTITY

adults 50 and over

Coverage of adults 50 and over in the Nexus archive.

Earliest in view: Jun 19 · 00:43 UTCMost recent: Jun 19 · 00:43 UTC

Co-mentioned in this coverage

Recent coverage

HEALTHJun 19 · 00:43 UTCNPR HEALTH
Key FDA committee unanimously recommends its first vaccine since 2023
A key FDA committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over. The recommendation marks the committee's first vaccine approval since 2023.